Humanized COVID‐19 decoy antibody effectively blocks viral entry and prevents SARS‐CoV‐2 infection
Kuo‐Yen Huang(National Defense Medical Center), Pan‐Chyr Yang(Institute of Biomedical Sciences, Academia Sinica), Han‐Chieh Kao(National Taiwan University), Rih‐Sheng Huang(University of Minnesota), Ci‐Ling Chen(Institute of Biomedical Sciences, Academia Sinica), Steven Lin(National Taiwan University), Ting‐Chun Kuo(National Taiwan University), Chung‐Chih Lin(Institute of Biomedical Sciences, Academia Sinica), Yu‐Chi Chou(Institute of Biomedical Sciences, Academia Sinica), Tai‐Ling Chao(National Taiwan University), M. L. Lin(Institute of Biomedical Sciences, Academia Sinica), Yu‐Hao Pang(National Taiwan University), Sui‐Yuan Chang(National Taiwan University of Science and Technology)
Cited by 64
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
RNA-programmed genome editing in human cells
|eLife|2013|2.1k
Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
|eLife|2014|1.2k
From Femtoseconds to Biology: Mechanism of Bacteriorhodopsin's Light-Driven Proton Pump
|Annual Review of Biophysics and Biophysical Chemistry|1991|532